This brand name is authorized in South Africa
The drug PUROMYLON contains one active pharmaceutical ingredient (API):
|
1
Nalidixic acid
UNII 3B91HWA56M - NALIDIXIC ACID
|
|
Nalidixic acid is a quinolone antibacterial agent for oral administration. Nalidixic acid and related drugs have been shown to cause arthropathy in juvenile animals of most species tested. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01MB02 | Nalidixic acid | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MB Other quinolones |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ZA | Health Products Regulatory Authority | Identifier(s): K/18.5/247 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
